Hematology CME

Credits: 1.50 CME / CNE
Penn State College of Medicine / Medical Learning Institute, Inc.
An Oncology Nurse MasterClass on Oral Therapy in B-Cell Malignancies: Insights on Evidence, Practical Strategies, and the Nurse-Patient Partnership
Barbara Barnes Rogers, CRNP, MN, AOCN, ANP-BC
22 May, 2019
Credits: 1.50 CNE / CE
Medical Learning Institute, Inc.
Taking Aim at B-Cell Malignancies With BTK Inhibitors: Oncology Nurse Perspectives and Insights on Clinical Care
Mollie Moran, APRN-CNP, AOCNP
16 May, 2019
Credits: 1.50 CME / CNE
Penn State College of Medicine
BTK Inhibition as an Anti-Cancer Strategy: Exploring a Model for Modern Targeted Therapy in Hematologic Malignancies and Beyond
John Byrd, MD
6 May, 2019
Credits: 1.00 CME / CNE
Penn State College of Medicine / Medical Learning Institute, Inc.
Oncology Nurse Insights Into New Agent Classes and Research in B-Cell Lymphoma: Practical Issues and Evidence for the Front-Lines of Care
Amy Goodrich, NP
30 April, 2019
Credits: 1.00 CME
Medical Learning Institute, Inc.
Progress and Promise With Immunotherapy in Resectable Melanoma: Exploring New Evidence and Practical Issues With Checkpoint Inhibitors as Adjuvant Therapy
Jason J. Luke, MD, FACP / Jennifer Wargo, MD, MMSc
25 April, 2019
Credits: 1.00 CME
The Medical College of Wisconsin
Innovative Therapeutic Concepts for ASCT-Eligible Patients With Myeloma: Advancing Toward More Effective Care Across Treatment Settings
Sagar Lonial, MD, FACP
10 April, 2019
Credits: 1.00 CME
The Medical College of Wisconsin
Attacking the Clinical Problem of VOD/SOS in HCT Recipients: Insights on Pathophysiology, Diagnosis, and Treatment
Mitchell Cairo, MD
3 April, 2019
Credits: 1.00 CME
The Medical College of Wisconsin
Harnessing Recent Advances in CAR-T Cell Therapy for Leukemia and Lymphoma in the Era of Stem Cell Transplantation
Tanya Siddiqi, MD / Shannon L. Maude, MD, PhD
2 April, 2019
Credits: 1.00 CME
The Medical College of Wisconsin
Integrating Innovative Therapeutics With Allogeneic HCT in AML: Insights and Evidence From Induction to Maintenance
Alexander Perl, MD / James M. Foran, MD, FRCPC
29 March, 2019
Credits: 1.00 CME
The Medical College of Wisconsin
Innovative Therapies in Post-Transplant GVHD: Personal Insights From the Patient CaseBook
Madan Jagasia, MBBS, MS, MMHC
28 March, 2019
Credits: 1.00 CME
The Medical College of Wisconsin
Managing CMV in the New Era of Antiviral Therapy: Practical Considerations in the HCT Setting
Roy Chemaly, MD, MPH, FIDSA, FACP
26 March, 2019
Credits: 0.50 CME
University of Nebraska Medical Center
Exploring Clinical Decisions in the New Era of Myeloma Management: The Impact of Novel Platforms and Agent Classes Across the Spectrum of Care
Luciano Costa, MD, PhD
13 March, 2019
Credits: 0.50 CME
Penn State College of Medicine
Defining the Role of Extended Half-Life Replacement Clotting Factors in the Modern Management of Hemophilia A
Guy Young, MD
25 February, 2019
Credits: 1.00 CME / CNE
Penn State College of Medicine / Medical Learning Institute, Inc.
Building Innovative Treatment Options for Patients With B-Cell Malignancies: Practical Insights on Clinical Evidence and Integration Strategies
Nathan Fowler, MD
15 February, 2019
Credits: 0.50 CME / MOC / CNE / CPE
University of Florida College of Medicine / Medical Learning Institute, Inc.
Turning the Tide on Venous Thromboembolism: Applying Anticoagulation Best Practices to Reduce the Disease Burden
Gregory Piazza, MD, MS
1 February, 2019
Credits: 0.50 CME
Medical Learning Institute, Inc.
Progress in Developing Novel Treatment Options for PTCL: Expert Views on Integrating Innovative Therapeutics Into Care
Younes Anas, MD
29 January, 2019
Credits: 2.00 CME
Medical Learning Institute, Inc.
Exploring the Present and Future of BTK Inhibition in B-Cell Malignancies: Expert Insights on Practical Implications for Patient Management
Andre Goy, MD
21 December, 2018
Credits: 0.75 CME / MOC / CNE
Medical Learning Institute, Inc.
The Oncologist, Nurse, and Patient Partnership in AML: Multiple Perspectives on Integrating Targeted Therapy Into Care
Amir Fathi, MD
5 December, 2018
Credits: 1.50 CME / MOC / CE
Medical Learning Institute, Inc.
Improving Patient Outcomes With Cancer Immunotherapies Throughout the Lung Cancer Continuum: State of the Science and Implications for Practice
Edward Garon, MD, MS
22 November, 2018
Credits: 1.50 CME / MOC / CE
Medical Learning Institute, Inc.
Emergency Medicine and Immuno-Oncology Intersect: Recognizing and Managing Cancer Immunotherapy–Related Adverse Effects in the Emergency Department
Daniel Pallin, MD, MPH
21 November, 2018
Credits: 1.00 MOC / CME / CE
Medical Learning Institute, Inc.
Treatment Innovation in Hemophilia A: Integrating Extended Half-Life Replacement Clotting Factors Into Clinical Practice
Mark Reding, MD
6 November, 2018
Credits: 1.00 CME
Medical Learning Institute, Inc.
Integrating BTK Inhibitors Into the Management of B-Cell Malignancies: How Is Evidence Driving Patient Care?
Michael Wang, MD
12 October, 2018
Credits: 1.50 CME
Penn State College of Medicine
Innovative Therapy in B-Cell Malignancies: An Expert Tumor Board on Novel Agent Classes in CLL, FL, and MCL
Nathan Fowler, MD
9 October, 2018
Credits: 2.00 CME
Penn State College of Medicine
The Arrival of Novel Agent Classes in B-Cell Non-Hodgkin Lymphoma: A Personal Guide to Integrating New Therapy Into Patient Care
John Leonard, MD
5 July, 2018
Credits: 2.00 CME
Medical Learning Institute, Inc.
Making Therapeutic Choices for Diverse AML Populations: Exploring New Science, More Effective Treatment Options, and Impact on Patient Care
Farhad Ravandi, MD
3 July, 2018
Credits: 1.50 CME
Penn State College of Medicine
A Personal Look at Innovative Therapy and Meeting Patient Needs in Multiple Myeloma: How I Think, How I Treat
Robert Orlowski, MD, PhD
3 July, 2018
Credits: 2.00 CME
Medical Learning Institute, Inc.
Emerging Biomarkers, New Targets, and Rational Combinations: Are We on the Verge of the Next Generation of Immuno-Oncology?
Naiyer Rizvi, MD
18 June, 2018
Credits: 1.00 CME
Medical Learning Institute, Inc.
Reversal of Action: Addressing the Unmet Need for Universal Antidotes to Factor Xa Anticoagulants
Charles Pollack, MA, MD, FACEP, FAAEM, FAHA, FESC, FCPP
12 June, 2018
Credits: 0.50 CME
Medical Learning Institute, Inc.
Treatment Evolution in Newly Diagnosed Hodgkin Lymphoma: A Look at the Evidence and Implications for Practice
Anas Younes, MD
30 May, 2018